Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning and Wednesday afternoon:
----------
FTSE 100
----------
S&P CAPITAL IQ CUTS BG GROUP PRICE TARGET TO 1050 (1063) PENCE - 'SELL'
----------
CRED
By Sumeet Chatterjee and Ben Hirschler MUMBAI/LONDON, Feb 6 (Reuters) - Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge
Read more
ARM Holdings: HSBC reduces target price from 1120p to 1080p and stays with its overweight rating. Avon Rubber: WH Ireland raises target price from 650p to 765p and stays with its buy recommendation. Balfour Beatty: Liberum Capital ups target price from 300p to 350p retaining its buy recommendation
Read moreLONDON (Alliance News) - Vodafone has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafone is up 1.4%.
Meanwhile, AstraZeneca has opened down 2.1% after reporting lower revenue and profit
LONDON (Alliance News) - Vodafone has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafone is up 1.4%.
Meanwhile, AstraZeneca has opened down 2.1% after reporting lower revenue and profit
New York's top banking regulator has demanded documents from more than a dozen banks, opening a new front in the sprawling global investigation into alleged foreign exchange manipulation. Ben Lawsky, superintendent of New York's Department of Financial Services (DFS), sent requests to banks includin
Read moreLONDON (Alliance News) - Mixed data in Europe and the US Wednesday has kept equity markets subdued ahead of the major US jobs report and central bank meetings still to come this week. Meanwhile the pound has underperformed other major currencies after an unexpected drop in UK service sector activ
Read moreBy Ben Hirschler LONDON, Feb 5 (Reuters) - Two high-risk bets by GlaxoSmithKline on new ways to fight heart disease and cancer were dealt a double blow last year by dud clinical trials - but the company remains hopeful about both projects. Chief Executive Andrew Witty said on Wednesda
Read morePharmaceuticals stocks were among the better performers on Wednesday after fourth-quarter sales from sector giant GlaxoSmithKline (GSK) impressed. GSK, which has a market capitalisation of over £76bn, said that turnover edged up 2% to £6.9bn in the last three months of 2013; ahead of analysts who h
Read moreAB Foods was extending gains for a second session after analysts at Morgan Stanley said on Tuesday that the market was "fundamentally mis-pricing" its Primark retail chain. The company´s shares hit a new record high at 2,930p on the back of those comments. Hargreaves Lansdown´s interim results sh
Read moreLONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported higher fourth quarter profits as revenues increased and it cut costs, and it confirmed that it expects to launch late stage clinical trials on ten new drugs over the next two years. The performance was driven by str
Read more* 2014 sales seen up 2 percent, EPS to grow 4-8 percent * Expects to stay respiratory market leader post 2020 * Q4 sales 6.91 billion pounds vs consensus 6.84 billion * Q4 core earnings 30.1 pence vs consensus 30.2p * Shares gain 3 percent on upbeat outlook By Ben Hi
Read moreLONDON (Alliance News) - The FTSE 100 is on the verge of snapping a five day losing streak Wednesday, led higher by the likes of RSA Insurance Group, which unveiled its new chief executive, and GlaxoSmithKline, which has just reported strong results.
LONDON (Alliance News) - US stocks are called to open in negative territory Wednesday, having closed firmly higher Tuesday, as investors take a step back ahead of a raft of US macro-economic data. Wall Street shook off recent weaknesses to close higher Tuesday, with the DJIA closing up 0.5%
Read moreLONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported higher fourth quarter profits as revenues increased and it cut costs, and it confirmed that it expects to launch late stage clinical trials on ten new drugs over the next two years. The performance was driven by str
Read more
Last checked at